The influence of antibiotics and statins on inflammation in coronary disease.
Stojanović
Radan
R
School of Medicine, Department of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia and Montenegro.
Vasiljević
Zorana
Z
Prostran
Milica
M
Radovanović
Mina
M
Stefanović
Branislav
B
Radovanović
Nebojsa
N
Janković
Jelena
J
Lakicević
Mirko
M
Mitrović
Predrag
P
Lasica
Ratko
R
Nesić
Zorica
Z
Todorović
Zoran
Z
Stojanov
Marina
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007249:Inflammation
D000900:Anti-Bacterial Agents; D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors